Search Result "myeloma-associated osteolysis"


Bisphosphonate Therapy in the Treatment of Multiple Myeloma

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 3028-3036
Author(s): M. A. Lawson, J. Ashcroft, P. I. Croucher

Assessment of Bishosphonate Activity In Vitro

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 2970-2980
Author(s): L. M. Mitrofan, S. Auriola, H. Monkkonen, J. Monkkonen

Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1272-1283
Author(s): C.H. Buckle, H.L. Neville-Webbe, P.I. Croucher, M.A. Lawson

Editorial [Hot topic: Bisphosphonates and Bone Diseases: Past, Present and Future (Guest Editor: Dominique HEYMANN)]

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 2948-2949
Author(s): Dominique HEYMANN

Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 3015-3027
Author(s): J. T. Buijs, C. C.H.J. Kuijpers, G. van der Pluijm

Bisphosphonates as Treatment of Bone Metastases

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1262-1271
Author(s): Ingunn Holen, Robert E. Coleman

TGF-β Pathway as a Therapeutic Target in Bone Metastases

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1301-1312
Author(s): Patricia Juarez, Theresa A. Guise

Combined Therapies of Bone Disease with Bisphosphonates

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 2 Year: 2010 Page: 2988-2997
Author(s): S. P. Syddall, P. D. Ottewell, I. Holen

Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting

Journal: Current Cancer Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 46-54
Author(s): D. Santini, V. Virzi, M. E. Fratto, F. Bertoldo, R. Sabbatini, R. Berardi, N. Calipari, D. Ottaviani, T. Ibrahim

The Role of the Osteoimmune Axis in the Inflammation of the Inner Auditory Ear and with Regard to the Putative Anticarcinogenetic Principle: Part 2

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 9 Issue: 2 Year: 2010 Page: 120-129
Author(s): Henning M. Schramm

Previous   Next

Go To   Results 1 - 1 of 13

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy